Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The role of the N-methyl-D-aspartate (NMDA) neurotransmitter system in relation to psychoses is not completely understood, but represent a challenge in neurobiological research. The psychotic states induced by NMDA antagonists such as phencyclidine and ketamine have been described as being most similar to schizophrenia and the NMDA system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, has been shown to be impaired in psychotic and psychotomimetic states in healthy and schizophrenic subjects. In this study, pictures of natural and artificial objects were presented stereoscopically to 12 healthy male volunteers and depth perception assessed using an operationalized method. The effects of the psychotomimetic S-enantiomer of the anaesthetic ketamine in two different subanaesthetic doses were compared with those of a placebo. In spite of dose dependence and grave subjective and significant objective psychopathology, no significant impairment of binocular depth perception was found with (S)-ketamine. Implications related to memory function, perceptogenesis and ‘bottom-up’ processing in ketamine model psychosis and schizophrenia are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allison, T. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.5.415 · Cited by 882 · cited 1×
“There is also the possibility that ketamine fails to effect binocular depth inversion of faces because faces are uniquely processed by specific regions of the accessory visual cortex (Allison et al., 1999).”
BackgroundThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action
Frith, C. D., & Done, D. J. (1989) · Psychological Medicine · doi:10.1017/s003329170001240x · Cited by 551
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.805 · Cited by 392 · cited 1×
“Consequently, reduced glutamatergic activity in the brain has been suggested to be involved in the aetiology of schizophrenic symptomatology (Breier et al., 1997; Abi-Saab et al., 1998; Vollenweider, 1998).”
BackgroundCrick, F., & Koch, C. (1992) · Scientific American · doi:10.1038/scientificamerican0992-152 · Cited by 296
The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
Abi-Saab, W., D'Souza, D., Moghaddam, B., & Krystal, J. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979354 · Cited by 208
Reduced binocular depth inversion in schizophrenic patients
Schneider, U., Borsutzky, M., Seifert, J., Leweke, F. M., Huber, T. J., Rollnik, J. D., & Emrich, H. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00172-9 · Cited by 108 · cited 6×
“Obviously, (S)ketamine effects mimic psychopathological symptoms of schizophrenia but the binocular depth inversion data suggest that (S)-ketamine in subanaesthetic doses does not produce changes in visual perception that are identical to those seen in schizophrenic subjects using this paradigm (Schneider et al., 2002…”
BackgroundMethodResultInfluentialSelf-citationLeweke, F. M., Schneider, U., Thies, M., Münte, T. F., & Emrich, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050884 · Cited by 102 · cited 1×
“…tested (e.g. schizophrenia, sleep deprivation, cannabinoids, alcohol intoxikation and alcohol withdrawal) (Schneider et al., 1996a,b; Sternemann et al., 1997; Schneider et al., 1998; Leweke et al., 1999, 2000; Schneider et al., 2002), in spite of the fact that BPRS and OAVAV scores were high.”
BackgroundSelf-citationPropsychotische Veränderung der binokulären Tiefeninversion durch Schlafentzug
Sternemann, U., Schneider, U., Leweke, F. M., Bevilacqua, C. M., Dietrich, D. E., & Emrich, H. M. (1997) · Der Nervenarzt · doi:10.1007/s001150050167 · Cited by 21
Cited by
The Computational Anatomy of Psychosis
Adams, R. A., Stephan, K. E., Brown, H. R., Frith, C. D., & Friston, K. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00047 · Cited by 850
“In fact, the only trait phenomenon that ketamine does not reproduce is a reduced susceptibility to the hollow mask illusion (Passie et al., 2003).”
BackgroundFrom drugs to deprivation: A Bayesian framework for understanding models of psychosis
Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1561-0 · Cited by 367
“In contrast to THC, ketamine has no effect on the BDII, despite inducing perceptual changes and psychotic symptoms (Passie et al. 2003).”
BackgroundToward a neurobiology of delusions
Corlett, P. R., Taylor, J. R., Wang, X.-J., Fletcher, P. C., & Krystal, J. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.007 · Cited by 394
Glutamatergic model psychoses: prediction error, learning, and inference
Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229
(2013) · PubMed · Cited by 192
Metadata
- Authors
- Passie, T., Karst, M., Borsutzky, M., Wiese, B., Emrich, H. M., & Schneider, U.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2003-01
- Volume
- 17
- Issue
- 1
- Pages
- 51-56
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1974372420
- Cited by
- 27
- References
- 9
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man. https://app.cochat.ai/papers/10.1177/0269881103017001698
- The paper
- Passie, T., Karst, M., Borsutzky, M., Wiese, B., Emrich, H. M., & Schneider, U. (2003). Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man. Journal of Psychopharmacology. https://doi.org/10.1177/0269881103017001698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.